Article

Report on a case of pure cribriform carcinoma of the breast with internal mammary node metastasis: description of the case and review of the literature.

Division of Breast Surgery, European Institute of Oncology, Milan, Italy.
Tumori (Impact Factor: 1.09). 01/2006; 92(3):241-3.
Source: PubMed

ABSTRACT Pure ductal invasive carcinoma of the breast is more frequently associated with lymphatic invasion, lymph node involvement and high malignant histological grade than combined forms of breast carcinoma. Internal mammary node metastases are not frequently detected when the axillary nodes are negative.
We report our experience of a case of pure cribriform carcinoma, associated with an intraductal cribriform component, in which the sentinel axillary nodes were negative, while nodal and perinodal metastasis was detected in one internal mammary lymph node.
Data from the literature show that positive internal mammary nodes are an unusual finding when the axillary sentinel node is negative, especially in cases of cancer with a relatively good prognosis, such as cribriform cases.

Full-text

Available from: Giovanna Gatti, Jun 15, 2015
0 Followers
 · 
51 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nine cases of infiltrating cribriform carcinoma (ICC) of the breast are reported and the clinicopathological features, particularly the imaging findings, are analyzed in the present study. Sonograms revealed that all masses exhibited a hypoechoic internal echo texture (9/9) and that a number of masses presented with an irregular shape (8/9), obscure boundary (5/9), partially microlobulated (5/9) or well-circumscribed (4/9) margins, and an inhomogeneous echo (8/9). Mammographic imaging revealed increased radiological density masses (6/8), and sand-like calcification was not observed in all patients. In two patients, the tumors were mammographically occult. Magnetic resonance imaging performed on one patient revealed a slightly high signal intensity on fat-saturated T1- and T2-weighted images. Following contrast enhancement, a homogeneous early enhancement was revealed with a quick ascent and quick descent time-density curve. Immunohistochemistry revealed that all ICCs expressed estrogen receptor and progesterone receptor, but that none were positive for human epidermal growth factor receptor 2. The Ki-67 labeling index was 3.75% (range, 2-5%) in the tumor tissue. Four patients were treated with mastectomy and the others with breast-conserving surgery. Six clinically node-negative patients underwent sentinel lymph node biopsy; three then received axillary lymph node dissection. Following surgery, three patients received adjuvant chemotherapy, radiotherapy and hormonal therapy, respectively. With a median follow-up time of 38 months (range, 4-70 months), one patient developed local recurrence following breast-conserving surgery; axillary lymph nodes and distant metastases were not observed. This study confirms that this type of carcinoma has unique biological characteristics and a favorable prognosis, but that it remains possible to experience local recurrence.
    Oncology letters 02/2015; 9(4). DOI:10.3892/ol.2015.2972 · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Because of the vast heterogeneity of in situ breast lesions, the morphologic diagnosis of ductal carcinoma in situ (DCIS) is challenging. The objective of this article is to present a "pictorial journey" through the infrequently encountered variants of DCIS and benign and malignant DCIS mimickers to familiarize readers with these rare entities, since these lesions can be a source of infrequent diagnostic pitfalls. Recognition of these unusual variants is crucial for proper patient management. Unusual variants of DCIS and DCIS mimickers are presented in this article. Examples of DCIS with a high propensity for underdiagnosis or misclassification, pertinent immunoperoxidase workups, the results of prognostic/predictive markers, and relevant clinical follow-up are also provided in certain cases. The currently controversial entities are also discussed.
    Clinical Breast Cancer 10/2012; 12(5):347-63. DOI:10.1016/j.clbc.2012.07.008 · 2.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is increased understanding of the heterogeneity of breast tumors, with greater emphasis now being placed on histological and molecular profiles and, in particular, their implications for prognosis and therapy. This review addresses breast cancers of unusual histological subtype with an approximate incidence ≤1%. Given the rarity of these tumors, the literature contains primarily case reports, small series, and population-based studies. Data are heterogeneous and almost entirely retrospective, frequently gathered over long time periods, in the context of changing pathological techniques and reporting. In addition, our understanding of the disease biology and therapeutic context has also evolved significantly over this time. There is often limited information about the specific therapies used and the rationale for choosing such an approach. Meaningful comparisons of treatment modalities are not feasible and it is not possible to define management guidelines. Instead, this review correlates the available information to give an impression of how each subgroup behaves-of the favored surgical technique, responses to therapy, and prognosis-as well as the emerging molecular data, highlighting new research areas for potential target in clinical trials. Each tumor subtype described represents a small but real cohort of patients with breast cancer, and although inferences may be made from this review, we are mindful of the paucity of data. The management of each patient must be considered in the context of their unique clinical presentation and correlated with the evidence-based principles that apply to more common breast cancer histologies.
    The Oncologist 07/2012; 17(9):1135-45. DOI:10.1634/theoncologist.2012-0134 · 4.54 Impact Factor